Gene amplification technology is one of the most important technologies used in genomic projects and plays vital role in other application areas such as diagnostics. There are large number of gene- and signal-amplification technologies, from polymerase chain reaction to ligase chain reaction, transcription mediated amplification, and dendritic polymers. These technologies are widely used in various applications in research and clinical settings.
The global gene-amplification technologies market is expected to show considerable growth during the forecast period. This is attributed to successful completion of human genome projects which is expected to increase human genomic researches, development in molecular diagnostics, and increasing genomic research across the world. However factors such as high cost is limiting the growth of this market.
The global gene-amplification technologies market is segmented into three broad categories: by technology, by application, and by geography. Based on technology, the market is divided into target amplification, signal amplification, isothermal DNA amplification, cycling temperature DNA amplification, isothermal signal amplification, cycling temperature signal gene amplification, exponential gene amplification, and linear gene amplification.
The global gene-amplification technologies market, by application is categorized into forensics, paternity, identity, food safety, agri-diagnostics, and veterinary. Geographically, the global gene-amplification technologies market is segmented into North America, Europe, Asia and Rest of the World (RoW: Latin America, Pacific Countries, and Middle East & Africa).
Some of the major players in the global safety syringes market include Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Ambion, Inc. (U.S.), Bayer Corporation (Germany), Becton, Dickinson, and Co. (U.S.), Digene Corporation (U.S.), Bio-Rad Laboratories (U.S.), PerkinElmer, Inc. (U.S.), Takara Bio, Inc. (Japan), QIAGEN N.V. (Netherlands), and others.